ARH-77È˽¬Ï¸°û°×Ѫ²¡
»ù±¾ÐÅÏ¢
²úÆ·Æ·ÅÆ £ºÍ¨ÎµÉúÎï
ÖÐÎÄÃû³Æ £ºÈ˽¬Ï¸°û°×Ѫ²¡
ϸ°û¼ò³Æ £ºARH -77
ϸ°ûÐÎ̬ £ºÁܰÍĸϸ°ûÑù
Éú³¤ÌØÐÔ £ºÐü¸¡Ï¸°û
ÅàÑø»·¾³ £º¿ÕÆø£¬95% £»CO2£¬5% 37¡æ
¶³´æÌõ¼þ £º55% »ù´¡ÅàÑø»ù+40% FBS+ 5% DM SOÒºµª
ÍêÈ«ÅàÑø»ù £ºRPM I-1640(P M 150110)£«10% F B S(164210-50)£«1% P /S(P B 180120)
´«´ú²½Öè
¿Éͨ¹ý²¹³äÐÂÏÊÅàÑø»ù»òÕßÀëÐÄ»»ÒºÁ½ÖÖ·½Ê½Î¬³ÖÅàÑø£¬ÀëÐÄתËٲο¼1200 rpm £¨250g×óÓÒ£©£¬ÀëÐÄ3·ÖÖÓ
»»ÒºÆµ´Î £º2~ 3´Î/ÖÜ
´«´ú±ÈÀý£¨Ãܶȣ© £º1:2-1:3
ϸ°û±³¾°ÃèÊö
TheARH -77cellline w asestablished from the perip h eralblood ofapatien tsu ffering from IgG plasm acellleu kemia.Although established from cellstaken from a patien twithaplasm acellleu kemia,thislinehasbeen shown to bean EBV -transform ed Blym phobla stoidcelllin e.
±¶Ôöʱ¼ä £º110.4 hours(PubM ed= 566614);~30 hours(D SM Z)
¹©ÌåÄêÁä £ºÅ®ÐÔ,33Ëê
×éÖ¯À´Ô´ £ºÍâÖÜѪ
ϸ°ûÀàÐÍ £º×ª»¯Ï¸°ûϵ
¿¹Ô±í´ï £ºCD 11a+ ; CD19+ ; CD20+ ; CD28+ ; CD38- ; CD 49e+
ÉúÎﰲȫµÈ¼¶ £º2
ϸ°û±£²ØÖÐÐÄ £ºATCC ; C RL-1621 BC RC ; 60385C C TC C ; G D C0218
ÊÕµ½³£ÎÂϸ°ûºóÈçºÎ´¦Àí
ϸ°ûÅàÑøÏêϸ²Ù×÷²½ÖèÇë²ÎÕÕͨεÉúÎïϸ°ûÅàÑø²Ù×÷Ö¸ÄÏ
1. ÊÕµ½³£ÎÂϸ°ûºó£¬¼°Ê±ÅÄÕռǼÓÐÎÞ©Һ/Æ¿ÉíÆÆËðÏÖÏó¡£
2. ÓÃ75%¾Æ¾«²ÁÊÃϸ°ûÅàÑøÆ¿±íÃæ£¬ÏÔ΢¾µÏ¹۲ìϸ°û״̬¡£ÏȲ»Òª´ò¿ªÅàÑøÆ¿¸Ç£¬½«Ï¸°ûÖÃÓÚϸ°ûÅàÑøÏäÄÚ¾²ÖÃÅàÑø2-4Сʱ£¬ÒÔ±ãÎȶ¨Ï¸°û״̬¡£
3. ×ÐϸÔĶÁϸ°û˵Ã÷Ê飬Á˽âϸ°ûÏà¹ØÐÅÏ¢£¬ÈçÌù±ÚÌØÐÔ£¨Ìù±Ú/Ðü¸¡£©¡¢Ï¸°ûÐÎ̬¡¢ËùÓûù´¡ÅàÑø»ù¡¢ÑªÇå±ÈÀý¡¢ËùÐèϸ°ûÒò×Ó¡¢´«´ú±ÈÀý¡¢»»ÒºÆµÂʵȡ£
4. ¾²ÖÃÍê³Éºó£¬È¡³öϸ°ûÅàÑøÆ¿£¬¾µ¼ì¡¢ÅÄÕÕ£¬¼Ç¼ϸ°û״̬£¨ËùÅÄÕÕÆ¬ ½«×÷ΪºóÐø·þÎñÒÀ¾Ý£©£»½¨Òéϸ°û´«´úÅàÑøºó£¬¶¨ÆÚÅÄÕÕ¡¢¼Ç¼ϸ°ûÉú³¤×´Ì¬¡£
5. Èô¹Û²ìµ½Òì³£»òÕß¶Ôϸ°ûÓÐÒÉÎÊ£¬Ç뼰ʱ¸úÎÒÃÇÁªÏµ£»¶ÔÓÚϸ°ûÅàÑø²Ù×÷¼°ÅàÑø¡£¿É¸úÎÒÃǵļ¼ÊõÖ§³Ö½»Á÷¡£
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
